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Dear Editor,  
 
We read with great interest the ADA position statement on psychosocial care for people 
with diabetes by Young-Hyman et al (1). This statement complements previous 
international guidelines, including those of the International Society of Pediatric and 
Adolescent Diabetes (ISPAD) and the International Diabetes Federation (IDF) (2,3), 
underscoring the importance of psychosocial care in the context of diabetes 
management. We commend the authors for their efforts to offer a comprehensive 
overview of psychosocial problems that warrant our attention along with a set of 
evidence-based recommendations. There are two issues that in our view deserve more 
attention.  
First, while the authors acknowledge that psychological well-being is an important 
outcome of diabetes care, the recommendations are all focused on mental ill health. It is 
important to recognize that the absence of a (serious) mental health problem does not 
necessarily equate to well-being or good ‘quality of life’. This has repercussions for 
language and communication with the person with diabetes. We feel it is important to 
adopt a positive, affirmative approach to the psychosocial needs of the person with 
diabetes. If we want all diabetes care providers to deliver emotionally informed care, we 
should avoid over-pathologizing the experiences of individuals with diabetes into ill 
health states as opposed to wellbeing states. In essence, the first question (to all 
individuals with diabetes) should be “How well are you doing?”, rather than a screening 
question for eating disorder, depression or other psychopathology. We recommend 
including a positively framed measure of emotional well-being in routine assessment 
(e.g. WHO-5 Well-being Index) either as a first step or alongside a measure of emotional 
distress. There is ‘real-world’ evidence demonstrating the acceptability and 
effectiveness of such an approach (4).  
Second, and related to the previous point, the practice of screening deserves more 
thought, particularly with respect to patient acceptance. We should be aware that from 
the perspective of the person with diabetes, screening for psychopathology is not always 
welcomed, for example because of fear of stigmatization or low confidence in mental 
health services (5), and more so when screening becomes routine procedure of simply 
‘ticking the box’.  Also, a questionnaire score indicative of a mental health problem is not 
to be confused with a felt need for psychological care. Too often people with diabetes 
report high distress but do not express a need for professional help.  Asking the 
question: “Do you want support for these problems, professionally or otherwise?” is just 
as important as knowing whether a person is distressed. It is therefore imperative that if 
screening is applied as recommended by Young-Hyman et al, diabetes health care teams 
are trained to do so in a constructive, patient friendly manner and are able to make 
available culturally acceptable, affordable evidence-based treatment options in response 
to the identified psychosocial needs. We suggest putting more emphasis on these 
requirements when recommending screening for psychosocial problems as part of 
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